InvestorsHub Logo
Followers 0
Posts 59
Boards Moderated 0
Alias Born 03/26/2013

Re: SAVIS post# 11661

Sunday, 04/20/2014 10:22:41 AM

Sunday, April 20, 2014 10:22:41 AM

Post# of 48316
Gums, you summed up S3's and how this one pertains to ONCS's current circumstances very succinctly. New drug development is a marathon not a sprint and an S3 should be viewed as a watering station along the race route. Should the company need funding relatively quickly it allows them to raise it within several days.
If one has done their DD and believes in what the company management is doing look at a potential offering under an S3 as the time to pick up cheaper shares. Happy Easter everyone.